Article detail · 2014 · review
Effects of Allopurinol on Endothelial Dysfunction A Meta Analysis
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueAmerican Journal of Nephrology
- Catalog match (ISSN)American Journal of Nephrology
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
OBJECTIVE: Several studies have assessed the effect of allopurinol on endothelial function, but these studies were relatively small in size and used different methods of evaluating endothelial function. We conducted a meta-analysis to investigate the effect of allopurinol on both endothelial-dependent and -independent vasodilatation. METHODS: Electronic databases, Medline, PubMed, EMBASE, SCOPUS, EBSCO and the Cochrane Library Central Register of Clinical Trials were searched from January 1985 to July 2013 on clinical trials (randomized and non-randomized) which assessed the effect of allopurinol on endothelial function. We conducted a sensitivity analysis to assess the contribution of each study to the pooled treatment effect by excluding each study one at a time and recalculating the pooled treatment effect for the remaining studies. Treatment effect was significant if p < 0.05. We assessed for heterogeneity in treatment estimates using the Cochran Q test and the χ(2) statistic (with substantial heterogeneity defined as values >50%). RESULTS: The final analysis consisted of 11 studies (2 observational and 9 randomized). For the endothelial-dependent vasodilatation there were 6 studies, including 257 patients, that evaluated flow-mediated dilatation and 5 studies with 87 patients that reported data on forearm blood flow response to acetylcholine or flow-dependent vasodilatation. Overall, there was a significant increase in the endothelium-dependent vasodilatation with allopurinol treatment (MD 2.69%, 95% CI 2.49, 2.89%, p < 0.001; heterogeneity χ(2) = 319.1, I(2) = 96%, p < 0.001). There was only 1 study (100 patients) assessing nitrate-mediated dilatation and 4 studies (73 patients) evaluating forearm blood flow response to sodium nitroprusside as measures of endothelial-independent vasodilatation. The overall analysis (MD -0.08, 95% CI -0.50, 0.34, p = 0.70; heterogeneity χ(2) = 9.0, I(2) = 44%, p = 0.11) showed no effect of allopurinol treatment on endothelium-independent vasodilatation. CONCLUSIONS: We found that treatment of hyperuricemia with allopurinol is associated with an improvement in the endothelial-dependent, but not with the endothelial-independent vasodilatation.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
56citationsOpenAlex · cited_by_count (cache / database)
10 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2017 Serum Uric Acid and Risk for Acute Kidney Injury Following Contrast: An Evaluation of Epidemiology, Clinical Trials, and Potential MechanismsCitations 50 · OpenAlex
- 2017 Serum Uric Acid and Risk for Acute Kidney Injury Following ContrastCitations 50 · OpenAlex
- 2017 Uric Acid is a Useful Tool to Predict Contrast-Induced NephropathyCitations 37 · OpenAlex
- 2017 Uric Acid is a Useful Tool to Predict Contrast-Induced NephropathyCitations 37 · OpenAlex
- 2022 The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative ReviewCitations 32 · OpenAlex
- 2020 The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast NephropathyCitations 22 · OpenAlex
- 2020 The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast NephropathyCitations 22 · OpenAlex
- 2019 The role of uric acid in mineral bone disorders in chronic kidney diseaseCitations 20 · OpenAlex
- 2020 Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancerCitations 3 · OpenAlex
- 2019 Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non‐small‐cell lung cancerCitations 3 · OpenAlex